Measuring Binding Kinetics of Antibody-Conjugated Gold Nanoparticles with Intact Cells.

Antibody-conjugated nanomaterials have attracted much attention because of their applications in nanomedicine and nanotheranostics, and amplification of detection signals. For many of these applications, the nanoconjugates must bind with a cell membrane receptor (antigen) specifically before entering the cells and reaching the final target, which is thus important but not well understood. Here, a plasmonic imaging study of the binding kinetics of antibody-conjugated gold nanoparticles with antigen-expressing cells is presented, and the results are compared with that of the nanoparticle-free antibody. It is found that the nanoconjugates can significantly affect the binding kinetics compared with free antibody molecules, depending on the density of the antibody conjugated on the nanoparticles, and expressing level of the antigen on the cell membrane. The results are analyzed in terms of a transition from monovalent binding model to a bivalent binding model when the conjugation density and expressing level increase. These findings help optimize the design of functional nanomaterials for drug delivery and correct interpretation of data obtained with nanoparticle signal amplification.

[1]  Hyesung Jeon,et al.  Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Pavel Zrazhevskiy,et al.  Quantum dot imaging platform for single-cell molecular profiling , 2013, Nature Communications.

[3]  M. Natan,et al.  Colloidal Au-enhanced surface plasmon resonance immunosensing. , 1998, Analytical chemistry.

[4]  F. Monsma,et al.  Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugs , 2010, Expert opinion on drug discovery.

[5]  C. Mirkin,et al.  Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. , 2007, Nano letters.

[6]  H. Mao,et al.  Investigations of bivalent antibody binding on fluid-supported phospholipid membranes: the effect of hapten density. , 2003, Journal of the American Chemical Society.

[7]  X. Qu,et al.  Near‐Infrared Light‐Triggered, Targeted Drug Delivery to Cancer Cells by Aptamer Gated Nanovehicles , 2012, Advanced materials.

[8]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[9]  Francesco Stellacci,et al.  Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.

[10]  J. Isola,et al.  Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line. , 2005, Cancer research.

[11]  R. Weissleder,et al.  Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.

[12]  Kenneth A Dawson,et al.  Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. , 2013, Journal of the American Chemical Society.

[13]  Sarah J. Hurst,et al.  Antibody-linked spherical nucleic acids for cellular targeting. , 2012, Journal of the American Chemical Society.

[14]  N. Thompson,et al.  Binding of a monoclonal antibody and its Fab fragment to supported phospholipid monolayers measured by total internal reflection fluorescence microscopy. , 1990, Biophysical journal.

[15]  Wei Sun,et al.  Single particle orientation and rotation tracking discloses distinctive rotational dynamics of drug delivery vectors on live cell membranes. , 2011, Journal of the American Chemical Society.

[16]  Iseult Lynch,et al.  Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. , 2011, Small.

[17]  E. Feil,et al.  S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation. , 2008, Molecular immunology.

[18]  V. Rotello,et al.  Surface functionality of nanoparticles determines cellular uptake mechanisms in mammalian cells. , 2013, Small.

[19]  Yunze Yang,et al.  Label-free measuring and mapping of binding kinetics of membrane proteins in single living cells. , 2012, Nature chemistry.

[20]  H. Ho,et al.  Nanomaterials enhanced surface plasmon resonance for biological and chemical sensing applications. , 2014, Chemical Society reviews.

[21]  S. Curley,et al.  Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis , 2010, Proceedings of the National Academy of Sciences.

[22]  Jun Ding,et al.  Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers. , 2012, Biomaterials.

[23]  J. Jenkins,et al.  Bivalent Sequential Binding Model of a Bacillus thuringiensis Toxin to Gypsy Moth Aminopeptidase N Receptor* , 2000, The Journal of Biological Chemistry.

[24]  Jeffrey N. Anker,et al.  Biosensing with plasmonic nanosensors. , 2008, Nature materials.

[25]  G. Adams,et al.  Monoclonal antibody therapy of cancer , 1999, Nature Biotechnology.

[26]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[27]  Seungpyo Hong,et al.  The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .

[28]  Xiaobo Yu,et al.  In situ drug-receptor binding kinetics in single cells: a quantitative label-free study of anti-tumor drug resistance , 2014, Scientific Reports.

[29]  X. Qu,et al.  Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: dual stimuli-responsive vehicles for intracellular drug delivery. , 2011, Angewandte Chemie.